MedTrace Logo

Comparison of CorWatch With Right Heart Catheter Measurements in Heart Failure

NCT04928326 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 43

Last updated 2024-03-06

No results posted yet for this study

Summary

This is an observational study to evaluate the agreement between the InCardia diagnostic technology CorWatch for the assessment of venous pressure in human subjects. This includes evaluation of InCardia technology in heart failure (HF) patients undergoing invasive right heart catheterization in a cardiac catheterization laboratory (cath lab) and in a cardiac intensive care unit (ICU).

Conditions

Interventions

DIAGNOSTIC_TEST

CorWatch

Non-invasive wearable monitor for the assessment of central venous pressure

Sponsors & Collaborators

Eligibility

Min Age
21 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-01
Primary Completion
2022-09-01
Completion
2022-10-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04928326 on ClinicalTrials.gov